Purchase Order 36C25626P0522

The Department of Veterans Affairs' Veterans Integrated Service Network 16 (VISN 16) awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. for prosthetic services, with performance in Biloxi, Mississippi and completion targeted by September 30, 2026. This award was issued without set-aside designation and represents a direct procurement from Novocure, a specialized medical device manufacturer that serves as the primary provider of Tumor Treating Fields therapy systems to the VA healthcare system. The purchase order falls under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) valued at $28.85 million, which was established on November 1, 2022, and remains active through October 31, 2027.

Novocure supplies innovative cancer treatment technologies, including the Optune system and associated transducer components, exclusively to VA medical centers nationwide. As a foreign-owned, for-profit company, Novocure acts as the sole source provider of these proprietary, non-invasive therapeutic devices for solid tumor cancers, with FDA approvals for glioblastoma and mesothelioma applications. The VA has issued over 100 individual delivery orders and purchase orders to Novocure under the FSS vehicle, with task orders distributed across VISNs serving veterans at multiple facilities. All contracts maintain firm fixed-price structures with no subcontractor involvement, ensuring direct quality control over the specialized medical device technology supporting the VA's strategic objective to expand veterans' access to advanced oncology solutions.